These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19588916)

  • 41. Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.
    Fulda S
    Leukemia; 2014 Jul; 28(7):1414-22. PubMed ID: 24487414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting IAP proteins for therapeutic intervention in cancer.
    Fulda S; Vucic D
    Nat Rev Drug Discov; 2012 Feb; 11(2):109-24. PubMed ID: 22293567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
    Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
    Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IAP inhibitors enhance co-stimulation to promote tumor immunity.
    Dougan M; Dougan S; Slisz J; Firestone B; Vanneman M; Draganov D; Goyal G; Li W; Neuberg D; Blumberg R; Hacohen N; Porter D; Zawel L; Dranoff G
    J Exp Med; 2010 Sep; 207(10):2195-206. PubMed ID: 20837698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale.
    Yang C; Novack DV
    J Bone Miner Metab; 2013 Sep; 31(5):496-506. PubMed ID: 23740289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Discovery--ESH's Eighth International Conference. October 14-17, 2010, Cascais, Portugal.
    Vucic D
    IDrugs; 2010 Dec; 13(12):836-9. PubMed ID: 21154138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists.
    Asano M; Hashimoto K; Saito B; Shiokawa Z; Sumi H; Yabuki M; Yoshimatsu M; Aoyama K; Hamada T; Morishita N; Dougan DR; Mol CD; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2013 Sep; 21(18):5725-37. PubMed ID: 23928071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IAPs as a target for anticancer therapy.
    Danson S; Dean E; Dive C; Ranson M
    Curr Cancer Drug Targets; 2007 Dec; 7(8):785-94. PubMed ID: 18220537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeutics.
    Wang S; Bai L; Lu J; Liu L; Yang CY; Sun H
    J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):217-28. PubMed ID: 23054134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IAP proteins: blocking the road to death's door.
    Salvesen GS; Duckett CS
    Nat Rev Mol Cell Biol; 2002 Jun; 3(6):401-10. PubMed ID: 12042762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of an inhibitor of apoptosis in the Egyptian armyworm, Spodoptera littoralis, and midgut cell death during metamorphosis.
    Vilaplana L; Pascual N; Perera N; Bellés X
    Insect Biochem Mol Biol; 2007 Dec; 37(12):1241-8. PubMed ID: 17967343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy.
    Fulda S
    Anticancer Agents Med Chem; 2008 Jun; 8(5):533-9. PubMed ID: 18537535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP.
    Vamos M; Welsh K; Finlay D; Lee PS; Mace PD; Snipas SJ; Gonzalez ML; Ganji SR; Ardecky RJ; Riedl SJ; Salvesen GS; Vuori K; Reed JC; Cosford ND
    ACS Chem Biol; 2013 Apr; 8(4):725-32. PubMed ID: 23323685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death.
    Kajiya M; Shiba H; Fujita T; Takeda K; Uchida Y; Kawaguchi H; Kitagawa M; Takata T; Kurihara H
    J Cell Physiol; 2009 Dec; 221(3):696-706. PubMed ID: 19711359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanisms of apoptosis and roles in cancer development and treatment.
    Goldar S; Khaniani MS; Derakhshan SM; Baradaran B
    Asian Pac J Cancer Prev; 2015; 16(6):2129-44. PubMed ID: 25824729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel promising IAP antagonist on the horizon for clinical translation.
    Fulda S
    J Med Chem; 2012 May; 55(9):4099-100. PubMed ID: 22515144
    [No Abstract]   [Full Text] [Related]  

  • 57. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells.
    Togano T; Sasaki M; Watanabe M; Nakashima M; Tsuruo T; Umezawa K; Higashihara M; Watanabe T; Horie R
    Biochem Biophys Res Commun; 2009 Dec; 390(1):60-4. PubMed ID: 19778522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting IAPs as an approach to anti-cancer therapy.
    Straub CS
    Curr Top Med Chem; 2011; 11(3):291-316. PubMed ID: 21320059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.
    Holcík M
    Expert Opin Ther Targets; 2004 Jun; 8(3):241-53. PubMed ID: 15161430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.